PPARG and fatty liver disease: In conclusion, our data indicate that VPA may enhance hepatic steatosis via increasing the protein expression and transcriptional activity of PPARγ, as well as by inducing the expression of downstream genes including Cd36, Dgat2, and Plin2 to increase lipid uptake, TAG synthesis, and lipid droplet formation in hepatocytes.